AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) insider John G. Chou sold 15,937 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $82.42, for a total transaction of $1,313,527.54. Following the completion of the sale, the insider now directly owns 67,226 shares in the company, valued at $5,540,766.92. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
AmerisourceBergen Corporation (NYSE ABC) opened at $85.99 on Thursday. The firm has a market cap of $18,731.06, a PE ratio of 14.58, a price-to-earnings-growth ratio of 1.49 and a beta of 1.00. The company has a quick ratio of 0.48, a current ratio of 0.91 and a debt-to-equity ratio of 1.83. AmerisourceBergen Corporation has a fifty-two week low of $71.90 and a fifty-two week high of $97.85.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Thursday, November 2nd. The company reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.01. The firm had revenue of $39.12 billion for the quarter, compared to analysts’ expectations of $40.10 billion. AmerisourceBergen had a net margin of 0.27% and a return on equity of 56.29%. The business’s revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.30 EPS. equities research analysts anticipate that AmerisourceBergen Corporation will post 6.07 earnings per share for the current year.
A number of equities research analysts have recently issued reports on ABC shares. Morgan Stanley cut shares of AmerisourceBergen from an “overweight” rating to an “equal weight” rating in a report on Thursday, September 14th. Mizuho set a $92.00 target price on shares of AmerisourceBergen and gave the company a “hold” rating in a report on Tuesday, October 24th. Zacks Investment Research cut shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. ValuEngine cut shares of AmerisourceBergen from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, Cowen raised shares of AmerisourceBergen from a “market perform” rating to an “outperform” rating in a report on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. AmerisourceBergen has a consensus rating of “Buy” and an average price target of $91.95.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. First Merchants Corp lifted its stake in AmerisourceBergen by 160.5% in the 3rd quarter. First Merchants Corp now owns 27,342 shares of the company’s stock valued at $2,262,000 after purchasing an additional 16,848 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its stake in AmerisourceBergen by 23.3% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,459 shares of the company’s stock valued at $369,000 after purchasing an additional 842 shares during the last quarter. Wedge Capital Management L L P NC lifted its stake in AmerisourceBergen by 17.3% in the 3rd quarter. Wedge Capital Management L L P NC now owns 494,216 shares of the company’s stock valued at $40,896,000 after purchasing an additional 72,743 shares during the last quarter. Achmea Investment Management B.V. lifted its stake in AmerisourceBergen by 7.8% in the 2nd quarter. Achmea Investment Management B.V. now owns 29,338 shares of the company’s stock valued at $2,770,000 after purchasing an additional 2,123 shares during the last quarter. Finally, Burgundy Asset Management Ltd. lifted its stake in AmerisourceBergen by 3.3% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 2,649,123 shares of the company’s stock valued at $250,422,000 after purchasing an additional 84,163 shares during the last quarter. Institutional investors and hedge funds own 67.83% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.com-unik.info/2017/12/07/amerisourcebergen-corporation-holding-co-abc-insider-sells-1313527-54-in-stock.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
What are top analysts saying about AmerisourceBergen Corporation (Holding Co)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AmerisourceBergen Corporation (Holding Co) and related companies.